David J. Sweeny

681 total citations
30 papers, 451 citations indexed

About

David J. Sweeny is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, David J. Sweeny has authored 30 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in David J. Sweeny's work include Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). David J. Sweeny is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). David J. Sweeny collaborates with scholars based in United States, United Kingdom and Switzerland. David J. Sweeny's co-authors include Robert B. Diasio, Myron Weiner, Stephen Barnes, Lester A. Reinke, H N Nellans, Muhammad Baluom, Elliott B. Grossbard, David Lau, Gary Park and Juthamas Sukbuntherng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

David J. Sweeny

30 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Sweeny United States	13	153	128	88	61	57	30	451
Naoaki Murao Japan	15	205 1.3×	161 1.3×	56 0.6×	30 0.5×	68 1.2×	26	624
David F. Gebhard United States	8	226 1.5×	148 1.2×	63 0.7×	68 1.1×	38 0.7×	12	544
Alain Dauphin France	12	188 1.2×	180 1.4×	31 0.4×	28 0.5×	40 0.7×	18	474
Yasuhiro Sato Japan	10	102 0.7×	85 0.7×	25 0.3×	110 1.8×	33 0.6×	27	510
Guo Li China	15	280 1.8×	126 1.0×	47 0.5×	62 1.0×	27 0.5×	27	639
Joseph Jamieson United States	5	308 2.0×	104 0.8×	81 0.9×	37 0.6×	18 0.3×	6	545
Vikram Malhi United States	11	234 1.5×	130 1.0×	81 0.9×	40 0.7×	14 0.2×	23	427
Nandi J. Reddy United States	10	193 1.3×	188 1.5×	69 0.8×	14 0.2×	64 1.1×	25	507
Clifford DiLea United States	11	119 0.8×	140 1.1×	71 0.8×	14 0.2×	55 1.0×	24	438
Richard W. Dyke United States	10	192 1.3×	157 1.2×	66 0.8×	40 0.7×	19 0.3×	13	415

Countries citing papers authored by David J. Sweeny

Since Specialization

Citations

This map shows the geographic impact of David J. Sweeny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Sweeny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Sweeny more than expected).

Fields of papers citing papers by David J. Sweeny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Sweeny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Sweeny. The network helps show where David J. Sweeny may publish in the future.

Co-authorship network of co-authors of David J. Sweeny

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Sweeny. A scholar is included among the top collaborators of David J. Sweeny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Sweeny. David J. Sweeny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shaw, Simon J., Dane A. Goff, D. C. Carroll, et al.. (2022). Structure activity relationships leading to the identification of the indirect activator of AMPK, R419. Bioorganic & Medicinal Chemistry. 71. 116951–116951. 2 indexed citations

Martin, Paul, Michael Gillen, David Millson, et al.. (2016). Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies. Drugs in R&D. 16(1). 81–92. 15 indexed citations

Martin, Paul, Michael Gillen, David Millson, et al.. (2015). Effects of Fostamatinib on the Pharmacokinetics of the CYP2C8 Substrate Pioglitazone: Results From In Vitro and Phase 1 Clinical Studies. Clinical Pharmacology in Drug Development. 5(3). 170–179. 5 indexed citations

Sweeny, David J., et al.. (2010). Contribution of gut bacteria to the metabolism of the spleen tyrosine kinase (Syk) inhibitor R406 in cynomolgus monkey. Xenobiotica. 40(6). 415–423. 14 indexed citations

Sweeny, David J., Weiqun Li, Rajinder Singh, et al.. (2010). Metabolism of Fostamatinib, the Oral Methylene Phosphate Prodrug of the Spleen Tyrosine Kinase Inhibitor R406 in Humans: Contribution of Hepatic and Gut Bacterial Processes to the Overall Biotransformation. Drug Metabolism and Disposition. 38(7). 1166–1176. 75 indexed citations

Haznedar, Joshua, Shem Patyna, Carlo L. Bello, et al.. (2009). Single- and multiple-dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species. Cancer Chemotherapy and Pharmacology. 64(4). 691–706. 56 indexed citations

Sweeny, David J., Juthamas Sukbuntherng, Qingling Zhang, et al.. (2005). Distribution, metabolism, and excretion of the anti-angiogenic compound SU5416. Toxicology in Vitro. 20(2). 154–162. 31 indexed citations

Sweeny, David J., et al.. (2000). Metabolism of the Influenza Neuraminidase Inhibitor Prodrug Oseltamivir in the Rat. Drug Metabolism and Disposition. 28(7). 737–741. 33 indexed citations

Lew, Willard, Paul A. Escarpe, Dirk B. Mendel, David J. Sweeny, & Choung U. Kim. (1999). Stereospecific synthesis of a GS 4104 metabolite: Determination of absolute sterochemistry and influenza neuraminidase inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 9(19). 2811–2814. 7 indexed citations

10.

Davidsen, Steven K., James B. Summers, David J. Sweeny, et al.. (1995). Synthesis of active metabolites of indole pyrrolothiazole paf antagonists. Bioorganic & Medicinal Chemistry Letters. 5(23). 2909–2912. 6 indexed citations

11.

Sweeny, David J. & H N Nellans. (1992). Enantiomeric activation of glucuronidation in dog hepatic microsomes.. Journal of Biological Chemistry. 267(19). 13171–13174. 9 indexed citations

12.

Sweeny, David J., Jennifer J. Bouska, Joseph M. Machinist, et al.. (1992). Glucuronidation of zileuton (A-64077) by human hepatic microsomes.. Drug Metabolism and Disposition. 20(2). 328–329. 14 indexed citations

13.

Sweeny, David J., Stephen Barnes, & Robert B. Diasio. (1991). Bile Acid Conjugation Pattern in the Isolated Perfused Rat Liver During Infusion of an Amino Acid Formulation. Journal of Parenteral and Enteral Nutrition. 15(3). 303–306. 9 indexed citations

14.

Johnson, Martin R., Stephen Barnes, David J. Sweeny, & Robert B. Diasio. (1990). 2-Fluoro-β-alanine, a previously unrecognized substrate for bile acid coenzyme A:Amino acid:N-acyltransferase from human liver. Biochemical Pharmacology. 40(6). 1241–1246. 9 indexed citations

15.

Sweeny, David J., et al.. (1990). Biological properties of the 2-fluoro-β-alanine conjugates of cholic acid and chenodeoxycholic acid in the isolated perfused rat liver. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1054(1). 21–25. 5 indexed citations

16.

Sweeny, David J. & Lester A. Reinke. (1988). Sulfation of acetaminophen in isolated rat hepatocytes. Relationship to sulfate ion concentrations and intracellular levels of 3'-phosphoadenosine-5'-phosphosulfate.. Drug Metabolism and Disposition. 16(5). 712–715. 18 indexed citations

17.

Sweeny, David J., M.H. Martin, & Robert B. Diasio. (1988). N-chenodeoxycholyl-2-fluoro-beta-alanine: a biliary metabolite of 5-fluorouracil in humans.. Drug Metabolism and Disposition. 16(6). 892–894. 11 indexed citations

18.

Shipley, Lisa A., Patrick I. Eacho, David J. Sweeny, & Myron Weiner. (1986). Inhibition of glucuronidation and sulfation by dibutyryl cyclic AMP in isolated rat hepatocytes.. Drug Metabolism and Disposition. 14(5). 526–531. 9 indexed citations

19.

Sweeny, David J. & Myron Weiner. (1985). Metabolism of acetaminophen in hepatocytes isolated from mice and rats of various ages.. Drug Metabolism and Disposition. 13(3). 377–379. 22 indexed citations

20.

Eacho, Patrick I., David J. Sweeny, & Myron Weiner. (1981). Effects of glucose and fructose on conjugation of p-nitrophenol in hepatocytes of normal and streptozotocin-diabetic rats. Biochemical Pharmacology. 30(18). 2616–2619. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact